-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The incidence and prevalence of atrial fibrillation continue to increase as the population ages and will continue to increase for decades to come .
As the population ages, the incidence and prevalence of atrial fibrillation continues to increase and will continue to increase for decades to come .
The aim of this study was to estimate the risk of cerebrovascular events in survivors of intracerebral hemorrhage complicated by atrial fibrillation
Blood vessel
We used the Danish Stroke Registry to identify patients with ICH and atrial fibrillation between 2003 and 2018, and applied key inclusion/exclusion criteria of the PRESTIGE-AF (Stroke Prevention Trial in Survivors of Cerebral Hemorrhage with Atrial Fibrillation)
A total of 1885 patients (median age, 80.
CONCLUSIONS : We observed a higher risk of cerebrovascular ischemic events and all-cause mortality one year after intracerebral hemorrhage
The researchers observed a higher risk of cerebrovascular ischemic events and all-cause mortality one year after intracerebral hemorrhage
Original source:
Peter Brønnum Nielsen.